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Background: The number of patients on hemodialysis complicated with critical limb ischemia (CLI) is increasing worldwide. Latest 
guideline points to life expectancy of <2 years as main determinant in revascularization modality selection (bypass surgery [BSX] or 
endovascular therapy [EVT]) in patients with critical limb ischemia (CLI). We compared clinical outcomes after EVT and after BSX, and 
examined predictors of 2-year mortality after revascularizaion in this setting.
methods: From 2007 to 2009, 246 consecutive CLI patients on hemodialysis (age, 69±10 years; 70% male; 45% non-ambulatory status; 
69% diabetics; 21% with rest pain; and 79% with tissue loss) who underwent revascularization for infrainguinal lesions (178 EVT and 68 
BSX) were enrolled. Two-year amputation-free survival (AFS), overall survival (OS), major amputation (MA), and major adverse limb event 
(MALE: repeat EVT, surgical reconstruction, major amputation) were evaluated by Kaplan-Meier analysis. Predictors for 2-year mortality 
after revascularization were determined using a Cox hazards model.
results: Two-year AFS, OS, MA, and MALE rates were not significantly different between EVT and BSX (60% vs. 52%, P=0.20; 80% 
vs. 69%, P=0.18; 15% vs. 18%, P=0.36; and 49% vs. 42%, P=0.40, respectively), which held after adjustment with covariates. However, 
death within 30 days was significantly higher after BSX than EVT (P=0.048). Predictors of 2-year mortality after EVT or BSX were age >75 
(hazard ratio [95% confidence interval], 1.79 [1.09-2.93]), and albumin <3g/dL (2.09 [1.21-3.59]).
conclusion:  After revascularization in CLI patients on hemodialysis, death rate within 30 days was higher in BSX than EVT; AFS, OS, 
MA, and MALE rates were not significantly different between EVT and BSX; older age and low albumin level were associated with 2-year 
mortality.
